NCT00984841

Brief Summary

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
467

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
Completed

Started Jan 2009

Shorter than P25 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 24, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 25, 2009

Completed
Last Updated

September 25, 2009

Status Verified

September 1, 2009

Enrollment Period

3 months

First QC Date

September 24, 2009

Last Update Submit

September 24, 2009

Conditions

Diabetes Mellitus

Keywords

Diabetes Mellitus targeted mailing

Outcome Measures

Primary Outcomes (1)

  • Diabetes summary quality measure

    4 months

Study Arms (2)

Tailored letter

EXPERIMENTAL

Patients in the tailored letter group received by mail a tailored letter detailing their diabetes measures, together with enclosed orders for lab tests when due, and reminder of or scheduling for an office appointment.

Other: Tailored letter

Usual Care

ACTIVE COMPARATOR

Patients in the usual care group were part of a practice wide quality improvement process.

Other: Tailored letter

Interventions

Tailored letterOTHER
Tailored letterUsual Care

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All active patients age 18 to 75 years with a diagnosis of diabetes mellitus were eligible.
  • An active patient was defined as one having an ICD-9 code on the active problem list identifying the patient as diabetic, and a progress note in the EMR associated with an office visit within the prior 12 months.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Scranton-Temple Health Center

Scranton, Pennsylvania, 18510, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • John R Guzek, MD

    Scranton-Temple Residency Program

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 24, 2009

First Posted

September 25, 2009

Study Start

January 1, 2009

Primary Completion

April 1, 2009

Study Completion

July 1, 2009

Last Updated

September 25, 2009

Record last verified: 2009-09

Locations

US(1)